Cite
HARVARD Citation
Raychaudhuri, S. et al. (2019). Quantitative tracking of inflammatory activity at the peak and trough plasma levels of tofacitinib, a Janus kinase inhibitor, via in vivo 18F‐FDG PET. International journal of rheumatic diseases. pp. 2165-2169. [Online].